Literature DB >> 22076541

Cortical lesions in radiologically isolated syndrome.

A Giorgio1, M L Stromillo, F Rossi, M Battaglini, B Hakiki, E Portaccio, A Federico, M P Amato, N De Stefano.   

Abstract

OBJECTIVE: To assess the presence of cortical lesions (CLs) as detected by MRI in subjects with radiologically isolated syndrome (RIS).
METHODS: Fifteen subjects with RIS underwent an MRI examination, including a double inversion recovery sequence for CL assessment. T2-hyperintense white matter (WM) lesion volume (LV) and normalized volumes of brain and cortex were also obtained.
RESULTS: Thirty-four CLs were identified in 6 of 15 (40%) subjects with RIS and predominantly distributed in frontotemporal lobes. CLs were frequent in subjects with RIS with immunoglobulin G oligoclonal bands on CSF, cervical cord lesions, and dissemination in time on brain MRI. WM LV was higher in subjects with CLs than in those without CLs (11.5 ± 10.1 vs 3.9 ± 2.8 cm(3), p = 0.04). Indeed, CL number and volume correlated with WM LV (r = 0.57, p = 0.03 and r = 0.61, p = 0.01). All subjects with CLs were classified in a previous study as having a very high probability of having relapsing-remitting multiple sclerosis (MS) on a logistic regression analysis of quantitative MRI indices.
CONCLUSIONS: We found CLs in subjects with RIS, a condition characterized by the unanticipated MRI finding of WM lesions highly suggestive of MS in the absence of a clinical scenario. CLs were mainly localized to the frontotemporal lobes and were associated with important markers of evolution to MS.

Entities:  

Mesh:

Year:  2011        PMID: 22076541     DOI: 10.1212/WNL.0b013e318238ee9b

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  30 in total

Review 1.  Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic process.

Authors:  Àlex Rovira; Mike P Wattjes; Mar Tintoré; Carmen Tur; Tarek A Yousry; Maria P Sormani; Nicola De Stefano; Massimo Filippi; Cristina Auger; Maria A Rocca; Frederik Barkhof; Franz Fazekas; Ludwig Kappos; Chris Polman; David Miller; Xavier Montalban
Journal:  Nat Rev Neurol       Date:  2015-07-07       Impact factor: 42.937

Review 2.  Multiple sclerosis.

Authors:  Massimo Filippi; Amit Bar-Or; Fredrik Piehl; Paolo Preziosa; Alessandra Solari; Sandra Vukusic; Maria A Rocca
Journal:  Nat Rev Dis Primers       Date:  2018-11-08       Impact factor: 52.329

Review 3.  Pharmacological Approaches to the Management of Secondary Progressive Multiple Sclerosis.

Authors:  A Nandoskar; J Raffel; A S Scalfari; T Friede; R S Nicholas
Journal:  Drugs       Date:  2017-05       Impact factor: 9.546

Review 4.  Treatment Considerations in the Radiologically Isolated Syndrome.

Authors:  Naila Makhani
Journal:  Curr Treat Options Neurol       Date:  2020-02-03       Impact factor: 3.598

5.  Reducing costs while enhancing quality of care in MS.

Authors:  Ilya Kister; John R Corboy
Journal:  Neurology       Date:  2016-09-02       Impact factor: 9.910

6.  Genetic associations with brain cortical thickness in multiple sclerosis.

Authors:  T Matsushita; L Madireddy; T Sprenger; P Khankhanian; S Magon; Y Naegelin; E Caverzasi; R L P Lindberg; L Kappos; S L Hauser; J R Oksenberg; R Henry; D Pelletier; S E Baranzini
Journal:  Genes Brain Behav       Date:  2015-03-05       Impact factor: 3.449

7.  Cortical Perfusion Alteration in Normal-Appearing Gray Matter Is Most Sensitive to Disease Progression in Relapsing-Remitting Multiple Sclerosis.

Authors:  S-P Hojjat; M Kincal; R Vitorino; C G Cantrell; A Feinstein; L Zhang; L Lee; P O'Connor; T J Carroll; R I Aviv
Journal:  AJNR Am J Neuroradiol       Date:  2016-03-24       Impact factor: 3.825

8.  Longitudinal Follow-up of a Cohort of Patients with Incidental Abnormal Magnetic Resonance Imaging Findings at Presentation and Their Risk of Developing Multiple Sclerosis.

Authors:  Mio Nakamura; Mark Morris; Mirela Cerghet; Lonni Schultz; Stanton Elias
Journal:  Int J MS Care       Date:  2014

Review 9.  Grey matter lesions in MS: from histology to clinical implications.

Authors:  Massimiliano Calabrese; Alice Favaretto; Valeria Martini; Paolo Gallo
Journal:  Prion       Date:  2012-10-23       Impact factor: 3.931

10.  Lesion Expansion in Experimental Demyelination Animal Models and Multiple Sclerosis Lesions.

Authors:  René Große-Veldmann; Birte Becker; Sandra Amor; Paul van der Valk; Cordian Beyer; Markus Kipp
Journal:  Mol Neurobiol       Date:  2015-09-12       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.